2Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med, 1991,325(5) :293 - 302.
3Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators. N Engl J Med, 1992,327(10) :685 - 691.
4MERIT- HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet, 1999,353:2001-2007.
5CIBIS- II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS - II): a mndomised trial. Lancet, 1999, 353:9-13.
6Packer M, Coats AJ, Fowler MB, et al, Carvedilol Prospective Randomised Cumulative Survival Study Group. Effect d carvedilol on survival in severe chronic heart failure. N Engl J Med, 2001, 344:1651 - 1658.
7Beta - Blocker Evaluation of Survival Trial Investigators. A trial of the beta - blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med, 2001,344:1659- 1667.
8Bristow MR. Adrenergie receptor blockade in chronic heart failure. Circulation, 2000, 101:558 - 569.
9Heart Failure Society d America. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction -pharmacological approaches. Pharmacotherapy, 2000, 20:495 - 522.
10Pitt B, Zannad F, Remme WJ, et al. The effect d spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med, 1999, 341(10) :709 - 717.
